| SN. |
Smith & Nephew
|
FTSE 100 |
2.44 |
£9.7B |
1,163.00 |
1.04% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.52 |
£4.17B |
213.40 |
0.09% |
| UPR |
Uniphar
|
AIM |
0.45 |
£1.01B |
383.70 |
0.90% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
0.69 |
£880.03M |
219.00 |
0.23% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.02 |
£605.83M |
279.50 |
3.10% |
| NIOX |
Niox Group
|
AIM |
2.62 |
£249.05M |
59.00 |
% |
| TSTL |
Tristel
|
AIM |
3.74 |
£182.35M |
379.95 |
1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£110.85M |
25.30 |
1.00% |
| SPEC |
Inspecs Group
|
AIM |
|
£98.62M |
99.00 |
-0.30% |
| SDI |
SDI Group
|
AIM |
|
£92.42M |
88.65 |
-1.50% |
| CREO |
Creo Medical Group
|
AIM |
|
£64M |
14.00 |
-0.80% |
| KMK |
Kromek Group
|
AIM |
|
£55.03M |
8.10 |
8.70% |
| NCYT |
Novacyt SA
|
AIM |
|
£25.84M |
37.09 |
4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£15.69M |
17.88 |
0.60% |
| RUA |
RUA Life Sciences
|
AIM |
|
£15.52M |
24.00 |
-6.90% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£14.66M |
31.25 |
-0.40% |
| FAB |
Fusion Antibodies
|
AIM |
|
£13.44M |
10.46 |
25.90% |
| GENI |
Genincode
|
AIM |
|
£6.02M |
0.76 |
1.40% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.66M |
0.55 |
-2.30% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£2.49M |
0.55 |
-3.80% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.12 |
7.30% |